{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06193954",
            "orgStudyIdInfo": {
                "id": "VST100"
            },
            "organization": {
                "fullName": "VasoStar, LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions",
            "officialTitle": "Evaluation of a Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions in Patients With Chronic Angina Refractory to Maximally Tolerated Guideline Directed Medical Therapy",
            "acronym": "VST100",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "vasostar-vibrational-guidewire-system-to-facilitate-crossing-coronary-artery-chronic-total-occlusions"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-13",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-21",
            "studyFirstSubmitQcDate": "2023-12-21",
            "studyFirstPostDateStruct": {
                "date": "2024-01-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "VasoStar, LLC",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Summa Health",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The goal of this project is to provide an improvement in wire performance to expedite crossing difficult lesions in the coronary vasculature.",
            "detailedDescription": "This Early Feasibility Study (EFS) is proposed to evaluate the initial safety and efficacy of the VasoStar guidewire system to cross complex coronary vascular lesions in non-tortuous arterial segments which are resistant to crossing with a traditional interventional guidewire."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Total Occlusion of Coronary Artery",
                "Chronic Angina"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Participants may be enrolled in the trial if an attempt to cross the target lesion with a standard wire fails.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "VasoStar guidewire system",
                    "type": "EXPERIMENTAL",
                    "description": "The VasoStar guidewire system will be used to cross vascular occlusion lesions.",
                    "interventionNames": [
                        "Device: VasoStar guidewire system"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "VasoStar guidewire system",
                    "description": "The VasoStar Vibrational Guidewire System vibrates longitudinally at the distal segment of a wire with an electromagnetic source.",
                    "armGroupLabels": [
                        "VasoStar guidewire system"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with successful crossing of the target lesion with the VasoStar guidewire system",
                    "timeFrame": "1 day"
                },
                {
                    "measure": "Incidence of Treatment-Emergent Serious Adverse Events",
                    "description": "Number of device- or procedure- related serious adverse events",
                    "timeFrame": "30 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Improved 6-minute walk distance at 6 months following the VasoStar successful procedure",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Improved 6-minute walk distance at 12 months following the VasoStar successful procedure",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Improved score on the Seattle Angina Questionnaire at the 6-month visit compared to the score at baseline",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Improved score on the Seattle Angina Questionnaire at the 12-month visit compared to the score at baseline",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Reduced number of hospitalizations for cardiac symptoms within 1 year following the VasoStar procedure, compared to the reported number of hospitalizations following standard CTO procedures.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Reduced number of emergency room visits for cardiac symptoms within 1 year following the VasoStar procedure, compared to the reported number of hospitalizations following standard CTO procedures.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female, over 18 years of age, presenting with at least one ischemia inducing lesion in a native coronary artery that is refractory to standard guidewire crossing. Chronic total occlusion (CTO) is defined as 100% coronary blockage for over a 3-month duration documented either by prior catheterization or by clinical evaluation\n* Suitable candidate for non-emergent, coronary angioplasty\n* Documented de-novo or restenotic coronary chronic total occlusion defined as a lesion with TIMI 0 flow for at least 90 days refractory to conventional guidewire crossing\n* Left ventricle ejection fraction \\> 20% within the last 12 months.\n* For antegrade chronic total occlusion procedures, activated clotting time (ACT) should be \\> 300 sec\n* Chronic total occlusion in a non-tortuous arterial segment\n* Voluntarily sign a Patient Informed Consent Form specific to the study.\n* Physically and mentally willing to comply with all study requirements.\n\nExclusion Criteria:\n\n* Successful target lesion crossing with a conventional wire system prior to enrollment\n* Prisoners.\n* Pregnancy\n* Patient has an active implantable.\n* Extensive dissection created by refractory guidewire\n* Severe ongoing congestive heart failure (New York Heart Association Class IV symptoms)\n* Active infection\n* Uncontrolled Hypertension (Systolic blood pressure \\> 180 mm) at the time of the procedure\n* History of severe reaction to contrast media\n* Recent myocardial infarction (within 2 weeks)\n* In-stent target lesion\n* Severe cerebrovascular disease including history of prior stroke or transient ischemic attack within 1 month at the time of the procedure\n* Saphenous vein graft (SVG) chronic total occlusion or an in-stent chronic total occlusion\n* Short life expectancy due to other illnesses such as cancer or pulmonary, hepatic or renal disease\n* Participation in another investigational protocol at the time of the procedure",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mihaela Plesa",
                    "role": "CONTACT",
                    "phone": "440 266 8226",
                    "email": "fvtinfo@frantzgroup.com"
                }
            ],
            "locations": [
                {
                    "facility": "Emory University",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "William Nicholson, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "William Nicholson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Summa Health",
                    "city": "Akron",
                    "state": "Ohio",
                    "zip": "44034",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kevin Silver, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Kevin Silver, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.08144,
                        "lon": -81.51901
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4117",
                    "name": "Angina Pectoris",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "asFound": "Chronic",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}